Yoshitomo Hoshino, a physician-scientist at The University of Tokyo Hospital, has been recognized with the C. Wayne Bardin, M.D., International Travel Award for his work on autoimmune osteomalacia and bone mineral metabolism.
The European Society of Endocrinology and the European Hormone and Metabolism Foundation launch a global campaign to raise awareness about hormone balance and its impact on chronic diseases. Small steps can make a big difference in improving hormone health.
The Endocrine Society has appointed Manuel Tena-Sempere as the next Editor-in-Chief of its flagship journal Endocrinology. He brings innovative ideas and expertise in neuroendocrinology to further high-quality basic research papers. Tena-Sempere's vision aims to promote rigorous research and scientific collaboration.
Dr Ambrish Mithal, an Indian endocrinologist, has been awarded the prestigious IOF CSA Medal of Achievement for his groundbreaking work in advancing the field of osteoporosis. His pioneering efforts have significantly increased understanding and awareness of osteoporosis globally.
Professor Atsushi Suzuki, Chair of Endocrinology at Fujita Health University School of Medicine, Japan, received the IOF President's Award for his exceptional contributions to IOF. He has shared his expertise as a mentor and engaged member of the Capture the Fracture Governance.
Media professionals can register for ENDO 2025 to discuss groundbreaking research on obesity, diabetes, and more with world-renowned experts. The event features nearly 2,500 abstracts and over 200 sessions, offering a premier global conference in endocrinology research and clinical care.
Sun Lee, MD, MSc, receives AACE's Rising Star in Endocrinology Award for outstanding leadership and innovative research on thyroid disorders and iodine nutrition. The award honors physicians who demonstrate actionable outcomes in patient care, scientific endeavor, and education.
Donald Patrick McDonnell, a professor at Duke University School of Medicine, has been awarded the Endocrine Society's John D. Baxter Prize for his research on hormone therapies for treating breast and prostate cancers. His work led to the discovery of novel treatments for these cancers and has improved patient care.
A clinical trial found that semaglutide significantly reduced weekly alcohol craving, drinking quantity, and the frequency of heavy drinking days in adults with symptoms of alcohol use disorder. Participants who received semaglutide also consumed lower amounts of alcohol during laboratory tests.
Professor Ashley Grossman has received the prestigious 2025 Transatlantic Alliance Award for his groundbreaking work on neuroendocrine tumors and pituitary disorders. He is recognized for fostering relationships between endocrinologists in Europe and the US, promoting collaborative efforts that advance global endocrine research.
The European Society for Paediatric Endocrinology and the European Society of Endocrinology will host the first-ever joint Congress on May 10-13, 2025. The event aims to bring together paediatric and adult endocrine specialists from across Europe and the world to collaborate and celebrate endocrinology.
The global Commission recommends diagnosing obesity based on excess body fat measures and objective signs of illness, shifting from BMI-based definition. This approach aims to provide personalized care for individuals with clinical and pre-clinical obesity, facilitating fair allocation of healthcare resources.
The European Society of Endocrinology (ESE) and ESE Foundation will host the first-ever World Hormone Day on April 24, 2025. The campaign aims to raise public awareness of good hormone health and improve national political engagement for better prevention, diagnosis, and treatment of endocrine disease.
A study reveals that lower-income and minority mothers face disproportionate challenges in postpartum health due to inadequate social support systems. The research emphasizes the need for targeted policy interventions to improve maternal health equity, strengthen postpartum care, and reduce health disparities.
Dr. Seymour Reichlin's centennial celebration highlights his ongoing scientific impact, with recent collaborations yielding new insights into hormone therapies for cognitive enhancement and emotional homeostasis. His work has established neuroendocrinology as a distinct field, bridging neuroscience, endocrinology, and clinical medicine.
The European Society of Endocrinology (ESE) has published an updated curriculum for endocrinology training, aiming to harmonize training standards across Europe. The new curriculum emphasizes lifelong learning and professional skills, such as communication and leadership, to foster greater collaboration and knowledge exchange.
The editorial highlights how digital tools improve patient outcomes through better monitoring, individualized care, and seamless communication between patients and healthcare providers. Digital health innovations also address key challenges such as data privacy and accessibility.
Research published in The Journal of Clinical Endocrinology & Metabolism found that pregnant women with higher levels of PFAS during pregnancy were more likely to experience obesity and heart health issues later in life. Women with lower PFAS levels had healthier cardiometabolic outcomes at age 50.
A recent study published in The Journal of General Internal Medicine found that providers trained through the Project ECHO model improved diabetes care for nearly 900 patients, reducing their A1c levels by an average of 1.2%. This significant improvement indicates a reduced risk of microvascular complications.
A study published in Cardiovascular Diabetology found that higher blood glucose levels at admission significantly increase the risk of a poor functional prognosis or death within three months of an ischemic stroke. The study revealed that even a 10% increase in glucose levels raises the risk by 7%, and mortality risk by 88%.
A recent study published in The Journal of Clinical Endocrinology and Metabolism found that women who underwent menopause before age 46 were nearly twice as likely to develop breast cancer as other women of similar ages. Relatives of these women were also more likely to have breast, prostate, or colon cancer.
Researchers at City of Hope and Mount Sinai have demonstrated a combination treatment that increases human insulin-producing beta cells by 700% in mice with type 1 and type 2 diabetes. The study, published in Science Translational Medicine, provides a potential new approach to treating the disease.
Researchers from Mount Sinai and City of Hope demonstrate a combination treatment that increases human insulin-producing beta cells by 700% in mice with diabetes. This breakthrough could lead to new treatments for the hundreds of millions of people with diabetes worldwide.
A study found that a cuffless wrist monitor provides hundreds of readings in days, enabling clinicians to determine cardiovascular risk and improve hypertension care. The device's continuous readings help confirm diagnosis and guide medication titration, potentially revolutionizing hypertension management.
A review article identifies new drug targets for treating type 2 diabetes, including growth differentiation factor (GDF15) and TGF-β pathways. Metformin's mechanism of action is also reevaluated, revealing a novel pathway of inhibiting mitochondrial complex IV.
A study found that telemedicine increased access to endocrinology care for adults with type 2 diabetes and cardiovascular disease, particularly those in rural areas and lower socioeconomic status. This enhancement of care access was primarily due to overcoming transportation barriers, mobility challenges, and long travel times.
Researchers at USask have discovered a new peptide that lowers lipid accumulation in human liver cells, offering new avenues for treating metabolic diseases. The finding is hopeful news as there's a lack of new therapies available for these diseases.
The Joint Guideline provides guidance on diagnosing and treating GC-AI, a condition affecting at least 1% of the global population. The guideline aims to improve patient care and outcomes worldwide.
Research links higher blood sugar levels at gestational diabetes diagnosis to complications in newborns, including low blood sugar and large birth weight. Women diagnosed with gestational diabetes are also at a higher risk of developing type 2 diabetes after birth.
A large-scale Finnish study discovered a significant link between premature menopause and increased mortality risk. Women with spontaneous premature ovarian insufficiency were more than twice as likely to die of any cause or heart disease, but hormone replacement therapy reduced this risk by half for those using it for over six months.
Higher cortisol levels in the womb may lower a boy's IQ score at age 7, while higher urine cortisone levels may improve a girl's IQ score. Research suggests that prenatal exposure to cortisol affects cognitive function in children independently of sex.
A new study finds that fezolinetant significantly reduces the frequency and severity of hot flushes in menopausal women for up to 24 weeks without serious side effects. The drug, approved by the FDA and EMA, works by blocking a brain protein involved in regulating body temperature.
Researchers discovered a link between high arm fat and low bone quality, particularly in the spine. Those with excess body fat, regardless of BMI, had lower bone quality and strength in their vertebrae.
A new study found that telehealth can positively impact diabetes care by providing a home environment perspective. Researchers also identified the importance of clear patient guidelines and reviewing glucose trends during visits to make them efficient and effective.
Researchers have made a groundbreaking discovery linking a genetic defect in the MGP gene to autosomal dominant spondyloepiphyseal dysplasia, a rare skeletal disorder. The study highlights the importance of the MGP gene and its role in skeletal development, paving the way for potential therapeutic interventions.
Mount Sinai researchers have found that testosterone treatment is safer than previously reported, with a smaller degree of change in hematocrit levels. The study, involving over 6,670 transmasculine patients, suggests that providers can feel more comfortable prescribing testosterone as part of gender-affirming hormone therapy.
Researchers at Hudson Institute of Medical Research discovered a novel RUNX1 genetic variant linked to unexplained severe osteoporosis in young adults. The study's findings suggest that this mutation may be responsible for the condition's severity and potentially lead to targeted treatment options.
The American Thyroid Association has appointed Dr. Trevor E. Angell as the new Editor-in-Chief of Clinical Thyroidology. Dr. Angell succeeds Angela M. Leung and aims to continue the journal's upward trajectory. He brings expertise in thyroid diagnosis and treatment, having published research on thyroid nodules and molecular testing.
Researchers found that thyroid hormones of the mother during pregnancy affect the later activity of brown adipose tissue in offspring. High maternal thyroid hormone levels were associated with more active brown fat in offspring.
The special issue explores achievements and challenges in reproductive endocrinology and infertility medicine, presenting strategies to bridge the gap between societal obligations and practice. Access to care remains a challenge for varying populations within societies and underserved regions.
A small study found that treating newly diagnosed Type 1 diabetes patients with semaglutide significantly reduced their need for insulin. The medication's ability to stimulate insulin secretion from the beta cells of the pancreas allowed for the elimination of mealtime and basal insulin doses in most patients.
A Medical College of Wisconsin research team has identified a new role for liver protein tPA in influencing blood cholesterol levels. The study found that increased tPA production leads to decreased VLDL assembly in the liver, which may provide a novel target for heart disease treatment.
A new clinical study found that adjuvant treatment with Mitotane is not necessary for patients with low risk of recurrence if they have a complete R0 resection, low tumour stage and Ki-67 levels below 10%. This approach has shown no significant improvement in relapse rate but is associated with side effects.
A large study published in the Journal of Clinical Endocrinology & Metabolism has found that moderate to light alcohol consumption does not protect against obesity and type 2 diabetes. The research, which analyzed data from over 408,000 participants, confirmed that heavy drinking increases measures of obesity and risk of type 2 diabetes.
A new study found that higher doses of oral semaglutide improved regulation of blood sugar levels and weight loss compared to lower doses. Participants who received the 25mg and 50mg doses lost an average of 17.5 pounds, nearly twice as much weight loss as those who took the lowest dose.
A UK-wide study found that non-functioning pituitary microadenomas (NFPA) are more likely to shrink or disappear than grow within three years of monitoring. The study suggests that clinical guidelines should be changed, and a single scan three years after initial detection would be a safe and cost-effective way to manage NFPAs.
The global diabetes crisis is accelerating due to widening inequity, with structural racism and geographic disparities exacerbating the problem. The new Series projects that over 1.3 billion people will live with diabetes by 2050, with marginalized communities facing reduced access to care and worse health outcomes.
A recent single-hospital study found that among 82 transgender and gender-diverse adolescents treated between 2016-2018, only three chose to discontinue gender-affirming hormone therapy. The reasons for discontinuation were often due to external factors, not re-transitioning to the assigned sex at birth.
The Endocrine Society will discuss emerging technology and diabetes research, including a scientific statement on hormones and aging. Researchers will share studies on various aspects of endocrinology, such as PCOS, obesity, and endocrine-disrupting chemicals.
Researchers found that rural patients with diabetes met fewer of the D5 metric criteria, including no tobacco use and blood pressure control, compared to urban patients. Rural patients also had fewer outpatient visits and endocrinology visits, which may contribute to poorer health outcomes.
Researchers found that four weeks of shift work-like patterns in female mice disrupted their biological clock and reduced fertility. The study suggests that circadian disturbances impact female fertility and may lead to future prevention strategies.
A long-term study found that women experiencing moderate to severe hot flashes after menopause are more likely to develop metabolic syndrome and hypertension. Hormone replacement therapy may help prevent these conditions.
Researchers have created the first humanized mouse model for Congenital Adrenal Hyperplasia, a rare genetic disease affecting 1 in 15,000 births. The mouse model accurately mimics human symptoms and allows for testing of novel treatments and stem cell therapies.
The European Society of Endocrinology, ESE Foundation, and other partners mark the second European Hormone Day to promote better understanding of hormone roles and encourage change in health policy. The 'Milano Declaration' calls for stronger inclusion of endocrine health perspective in European policies.
Research finds that low vitamin D levels are associated with an increased risk of developing long COVID syndrome in patients who have previously contracted COVID-19. The study suggests that individuals with low vitamin D levels should have their levels checked after recovering from COVID-19.
High levels of cortisol during the third trimester of pregnancy have been linked to improved speech and language skills in young children. Research found that boys exposed to high cortisol had better word-saying abilities, while girls showed enhanced understanding skills.
A new study found that overweight boys tend to have lower testicular volume, putting them at risk for infertility in adulthood. The research suggests that weight loss could help patients avoid infertility later in life.
Researchers at CU Anschutz Medical Campus used metabolomics to study elite cyclists' metabolism during training and racing. The study identified healthy metabolomic signatures that can help detect dysregulations of key areas ahead of time, potentially leading to personalized exercise-as-medicine approaches for preventing chronic diseases.
Researchers found that GlyNAC supplementation corrected brain glutathione deficiency, improved glucose transporters, reversed mitochondrial dysfunction, and improved cognition in old mice. The study also showed reductions in oxidative stress, inflammation, and genomic damage, as well as improvements in neurotrophic factors.
A remote hypertension program, operated by Mass General Brigham, successfully supported patients through the COVID-19 pandemic in achieving their blood pressure goals. Participants who enrolled during the pandemic reached and maintained their goal blood pressures an average of two months earlier than in the pre-pandemic period.